Read more about the study on a potential pill for Parkinson’s.
Pill shows potential to help slow Parkinson’s disease progression
Author: Sarah McGrathPublished: 10 March 2022
Prep: Cook: Serves:
Researchers in Norway have shared findings on an oral supplement which may help to slow the progression of Parkinson’s.
The team recruited 30 adults recently diagnosed with Parkinson’s, who were not yet under dopamine-replacing therapies, to take part. Participants were given oral supplements of nicotinamide riboside (NR) – a form of vitamin B3 found in fruit, vegetables and other foods.
The pill was found to reduce levels of inflammatory proteins in fluid surrounding the brain and spinal cord, boost metabolism and encourage “mild but significant” improvement in participants’ symptoms when compared to the control group.
The researchers have now started a second phase of research involving 400 participants. “If that is positive,” said lead researcher Charalampos Tzoulis, “we could be looking at a new drug within the next five years.”
He emphasised the need for “further investigation” and cautioned against self-medicating with NR supplements until more is known.
For more information on the latest Parkinson’s disease research, please visit Parkinson’s Europe website.
Could self-compassion impact the wellbeing of people with Parkinson’s?
Lower risk of Parkinson’s disease after a heart attack, study suggests
Share this story
How a TikTok video inspired a new pill bottle design for Parkinson’s disease
A simple solution for “an everyday struggle”READ MORE
3 Parkinson’s disease symptoms you need to know about
Our readers discuss facial masking, sleep disturbance and voice problemsREAD MORE
Women and Parkinson's
The women blazing the trail in Parkinson’s tech and innovation
Have you heard about these Parkinson’s technology inventions?READ MORE